查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2085015

抗衰老治療市場：按治療類型、經營模式、療法類型、護理環境、提供者類型和性別分類－2026-2032全球市場預測

Anti-Ageing Treatment Market by Treatment Type, Business Model, Therapy Type, Care Setting, Provider Type, Gender - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，抗老治療市場將成長至 1,050.7 億美元，複合年成長率為 7.03%。

主要市場統計數據
基準年 2025 652.8億美元
預計年份：2026年 697.6億美元
預測年份 2032 1050.7億美元
複合年成長率 (%) 7.03%

抗老療程市場正從以改善外觀為重點的療程轉向以臨床為基礎、注重延年益壽、皮膚健康和預防性美容的方案。人口老化是推動此需求成長的主要因素。世界衛生組織（WHO）預測，60歲以上人口將從2020年的10億增加到2030年的14億，並在2050年達到21億，這將為除皺注射、皮膚填充劑、能量型醫療設備、外用活性成分、再生醫學療法和個人化健康方案等創造持續的需求基礎。

此外，人們對光老化、微創手術和皮膚科醫生主導的護理的認知不斷提高，正在影響消費者的接受度。受美國食品藥物管理局（FDA）目標產品，例如肉毒桿菌、透明質酸填充劑、雷射系統和微針設備，仍是市場信譽的基石。同時，處方類維他命A類視色素、頻譜防曬油、胜肽類、抗氧化劑和荷爾蒙療法等產品不斷拓展抗衰老生態系統，為臨床和消費者提供更多選擇。

抗老產業的變革

三大趨勢正在重塑市場競爭格局：「早期療育」、「個人化」以及「美容與健康的融合」。年輕消費者越來越傾向於選擇預防性護膚和恢復期短的療程，而年長消費者則追求自然的效果、功能性的肌膚改善以及能夠促進膠原蛋白重塑的療程，而不僅僅是撫平皺紋。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過影像分析、皮膚年齡評估、治療方案製定、患者分割和臨床工作流程最佳化等方式，對抗老化治療產生日益顯著的影響。 AI 驅動的臉部分析使臨床醫生能夠記錄患者的基準皮膚品質、色素沉著、鬆弛程度、紋理和皺紋深度，從而提高諮詢的一致性，並實現更個人化的抗衰老方案。

關鍵區域洞察

亞太地區已成為最具活力的抗衰老護膚之一，這得益於快速的都市化、濃厚的皮膚病學和美容文化、中國、日本、韓國、印度和澳洲等國對醫學美容的需求，以及人們對處方箋區域。

主要群體分析

東協市場正經歷成長，尤其是在新加坡、泰國、馬來西亞、印尼、越南和菲律賓，這主要得益於可支配收入的增加、社交電商的興起以及醫療旅遊的普及，這些因素都擴大了人們獲得美容皮膚科服務的機會。海灣合作理事會（GCC）地區的市場也在擴張，醫療費用支出，以及沙烏地阿拉伯、阿拉伯聯合大公國、卡達、科威特、巴林和阿曼等國對非手術臉部年輕化治療的強勁需求。

主要國家的概況

美國憑藉其龐大的認證皮膚科醫生和整形外科醫生群體、廣泛的FDA批准醫療設備以及消費者對注射療法的熟悉程度，在高階抗衰老治療領域主導。加拿大在許多方面都反映了美國的趨勢，但在臨床應用上則較為保守。墨西哥則受益於跨境美容醫療和具有成本競爭力的私人醫療保健系統。巴西對各種美容手術的接受度很高，並且是全球美容醫療中心之一。英國、德國、法國、義大利和西班牙則透過皮膚科診所、藥局和美容醫療機構，持續滿足成熟的歐洲市場的需求。

為行業領導者提供的實用建議

行業領導者應優先考慮基於證據的療效聲明、醫療專業人員教育以及兼顧安全性、有效性和自然效果的差異化治療方案。各機構需要投資於臨床試驗、真實世界數據、不利事件監測和透明的標籤，以增強皮膚科醫生、美容醫療專業人員、監管機構和知情消費者的信任。

調查方法

本執行摘要採用以二手資料研究主導的調查方法編寫，符合市場情報最佳實踐。資訊來源包括世界衛生組織 (WHO) 和聯合國人口與資源部的公開資料集和出版刊物、美國食品藥物管理局(FDA) 等國家監管機構和歐洲監管機構、皮膚病學和整形外科組織、同行評審文獻、公開產品標籤以及手術趨勢報告。

結論

抗衰老治療正朝著以科學主導、以技術為驅動、以預防為中心的方向發展。人口老化、人們對美容手術了解的增加、微創治療技術的進步，以及皮膚病學、健康管理和數位工具的融合，都在成熟市場和新興市場中創造了持續的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 抗老治療市場：依治療類型分類

  • 美容護理
    • 化學換膚
    • 低溫
    • 皮膚填充劑
    • 肉毒桿菌注射
    • 雷射皮膚修復
    • 微晶換膚
    • 微針療法
    • 高頻皮膚緊緻
  • 局部治療
    • 抗老乳霜和精華液
    • 抗氧化劑
    • 胜肽
    • 類視色素
    • 防曬油

第8章：抗老治療市場：依經營模式

  • 單品銷售
  • 重複補充模型
  • 訂閱式護膚模式

第9章 抗老治療市場：依療法類型分類

  • 單藥治療
  • 聯合治療

第10章：抗老治療市場：依護理環境分類

  • 居家照護
  • 美容美髮和水療護理
  • 在皮膚科診所接受治療
  • 在醫療機構接受治療

第11章 抗老治療市場：依服務提供者類型分類

  • 皮膚科醫生
  • 整形外科醫生
  • 醫療水療中心
  • 健康專家

第12章：抗老治療市場：依性別分類

  • 女士
  • 男性

第13章 抗老治療市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 抗老治療市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 抗老治療市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Allergan Plc by AbbVie Inc.
  • Alma Lasers Ltd.
  • Amorepacific Corporation
  • AVON Products, Inc.
  • Bausch & Lomb Incorporated
  • Beiersdorf AG
  • Coty Inc.
  • Cynosure, LLC
  • DSM-Firmenich AG
  • Evolus
  • Galderma SA
  • Kao Corporation
  • Kenvue Inc.
  • L'Oreal SA
  • Mary Kay Inc.
  • Merck KGaA
  • Merz Aesthetics
  • Natura & Co.
  • Nu Skin International, Inc.
  • Pierre Fabre SA
  • Revance Aesthetics
  • Shiseido Company, Limited
  • Solta Medical, Inc.
  • Syneron Medical Ltd.
  • The Estee Lauder Companies Inc.
  • The Procter & Gamble Company
  • Unilever PLC
Product Code: MRR-4358BACA7F08

The Anti-Ageing Treatment Market is projected to grow by USD 105.07 billion at a CAGR of 7.03% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 65.28 billion
Estimated Year [2026] USD 69.76 billion
Forecast Year [2032] USD 105.07 billion
CAGR (%) 7.03%

The anti-ageing treatment market is moving from appearance-focused interventions toward clinically guided longevity, skin health, and preventive aesthetics. Demand is supported by population ageing: the World Health Organization reports that people aged 60 years and older are projected to increase from 1.0 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050, creating a durable need base for anti-wrinkle injectables, dermal fillers, energy-based devices, topical actives, regenerative medicine approaches, and personalized wellness protocols.

Consumer adoption is also being shaped by higher awareness of photodamage, minimally invasive procedures, and dermatology-led care. FDA-regulated products such as botulinum toxin, hyaluronic acid fillers, laser systems, and microneedling devices remain central to market credibility, while prescription retinoids, broad-spectrum sunscreen, peptides, antioxidants, and hormone-related therapies continue to expand the clinical and consumer-facing anti-ageing ecosystem.

Transformative Shifts in the Anti-Ageing Landscape

The competitive landscape is being reshaped by three major shifts: earlier intervention, personalization, and convergence between aesthetics and wellness. Younger consumers are increasingly adopting preventive skin care and low-downtime procedures, while older consumers are seeking natural-looking outcomes, functional skin improvement, and treatments that support collagen remodeling rather than isolated wrinkle correction.

Scientific scrutiny is rising as regulators and clinicians emphasize evidence-based claims, product safety, post-market surveillance, and realistic patient expectations. This is pushing brands and providers toward substantiated clinical data, transparent ingredient positioning, physician-led education, and combination protocols that integrate injectables, lasers, radiofrequency, topical regimens, nutrition, and lifestyle management.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing anti-ageing treatment through imaging analytics, skin-age assessment, treatment planning, patient segmentation, and clinical workflow optimization. AI-enabled facial analysis can help clinicians document baseline skin quality, pigmentation, laxity, texture, and wrinkle depth, improving consultation consistency and enabling more personalized anti-ageing protocols.

The impact is cumulative because AI strengthens multiple points of the value chain: R&D teams use computational tools to screen bioactive ingredients, clinics use digital tools for procedure planning and follow-up, and brands use predictive analytics to tailor product recommendations. However, adoption must align with privacy rules, bias testing, medical-device requirements, and human clinical oversight, particularly when AI tools influence diagnosis, treatment selection, or outcome claims.

Key Regional Insights

Asia-Pacific is one of the most dynamic anti-ageing treatment regions, supported by rapid urbanization, strong dermatology and beauty cultures, medical aesthetics demand in China, Japan, South Korea, India, and Australia, and rising interest in preventive skin care. North America remains a high-value region due to advanced aesthetic medicine infrastructure, strong FDA oversight in the United States, high procedure awareness, and broad adoption of injectables, lasers, prescription dermatology, and premium cosmeceuticals.

Europe benefits from mature dermatology standards, European and national regulatory oversight, and a strong consumer preference for clinically validated, natural-looking, and sustainability-aligned solutions. Latin America is supported by an established aesthetic surgery and dermatology culture, with Brazil and Mexico acting as major demand centers. The Middle East is growing through premium clinics, medical tourism, and high spending on dermatology services, while Africa presents a longer-term opportunity as urban private healthcare, sunscreen awareness, and access to dermatology services improve.

Key Group Insights

ASEAN markets are expanding as rising disposable income, social commerce, and medical tourism increase access to aesthetic dermatology, particularly in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is advancing through premium clinic networks, high per-capita healthcare spending, and strong demand for non-surgical facial rejuvenation in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman.

The European Union offers scale through harmonized regulatory principles, high consumer safety expectations, and growing demand for evidence-backed dermocosmetics and device-based treatments. BRICS economies, including Brazil, Russia, India, China, South Africa, and newer BRICS+ members, represent a large demographic opportunity with diverse pricing and access needs. G7 countries remain critical for innovation, regulatory influence, dermatology standards, and premium product launches, while NATO markets overlap with many high-income healthcare systems where device compliance, supply-chain resilience, and clinical governance are central to commercialization.

Key Country Insights

The United States leads in premium anti-ageing treatments due to a large base of board-certified dermatologists and plastic surgeons, FDA-cleared devices, and strong consumer familiarity with injectables. Canada mirrors many U.S. trends with more conservative clinical adoption, while Mexico benefits from cross-border medical aesthetics and cost-competitive private care. Brazil is a global aesthetic powerhouse with high procedure acceptance, and the United Kingdom, Germany, France, Italy, and Spain continue to support mature European demand through dermatology clinics, pharmacies, and medical aesthetics providers.

Russia remains a sizable aesthetics market despite geopolitical and supply-chain complexity. China is expanding through urban middle-class demand and digital beauty ecosystems, India is growing on the back of dermatology access and younger preventive users, Japan emphasizes quality, subtle outcomes, and advanced skin care, Australia benefits from high UV-awareness and regulated aesthetic practice, and South Korea remains a global trendsetter in injectables, laser dermatology, skin boosters, and innovation-led beauty medicine.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed claims, clinician education, and differentiated treatment protocols that combine safety, efficacy, and natural-looking results. Organizations should invest in clinical studies, real-world evidence, adverse-event monitoring, and transparent labeling to strengthen trust with dermatologists, aesthetic physicians, regulators, and informed consumers.

Commercial strategies should localize by region: premium personalization in North America, Europe, Japan, South Korea, and the GCC; accessible dermatology-led offerings in India, Mexico, Brazil, and ASEAN; and medical tourism partnerships in selected hubs. Leaders should also adopt responsible AI for skin analysis and customer engagement while ensuring data protection, algorithmic fairness, and clinical supervision.

Research Methodology

This executive summary is developed using a secondary research-led methodology aligned with market intelligence best practices. Inputs include public datasets and publications from the World Health Organization, United Nations population resources, national regulators such as the U.S. FDA and European authorities, dermatology and aesthetic surgery associations, peer-reviewed literature, public product labeling, and procedure trend reports.

Insights are triangulated across demographics, regulatory developments, product innovation, clinical adoption, consumer behavior, regional healthcare infrastructure, and competitive positioning. The methodology emphasizes verified, data-backed interpretation and avoids unsupported market sizing, market share analysis, or forecasting where source consistency is insufficient.

Conclusion

Anti-ageing treatment is evolving into a science-led, technology-enabled, and prevention-oriented field. Population ageing, rising aesthetic literacy, improved minimally invasive procedures, and the integration of dermatology, wellness, and digital tools are creating sustained demand across mature and emerging economies.

The strongest opportunities will favor organizations that balance innovation with clinical credibility. Providers and product developers that combine regulated products, responsible AI, personalized protocols, physician partnerships, and region-specific access models are best positioned to support long-term growth in the global anti-ageing treatment landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Anti-Ageing Treatment Market, by Treatment Type

  • 7.1. Cosmetic Treatments
    • 7.1.1. Chemical Peels
    • 7.1.2. Cryotherapy
    • 7.1.3. Dermal Fillers
    • 7.1.4. Botox Injections
    • 7.1.5. Laser Skin Resurfacing
    • 7.1.6. Microdermabrasion
    • 7.1.7. Microneedling
    • 7.1.8. Radiofrequency Skin Tightening
  • 7.2. Topical Treatments
    • 7.2.1. Anti-aging Creams & Serums
    • 7.2.2. Antioxidants
    • 7.2.3. Peptides
    • 7.2.4. Retinoids
    • 7.2.5. Sunscreens

8. Anti-Ageing Treatment Market, by Business Model

  • 8.1. One-time product sale
  • 8.2. Repeat replenishment model
  • 8.3. Subscription skincare model

9. Anti-Ageing Treatment Market, by Therapy Type

  • 9.1. Monotherapy
  • 9.2. Combination Therapy

10. Anti-Ageing Treatment Market, by Care Setting

  • 10.1. At-Home Treatment
  • 10.2. Salon/Spa Treatment
  • 10.3. Dermatology Clinic Treatment
  • 10.4. Hospital-Based Treatment

11. Anti-Ageing Treatment Market, by Provider Type

  • 11.1. Dermatologists
  • 11.2. Plastic surgeons
  • 11.3. Medical spas
  • 11.4. Wellness practitioners

12. Anti-Ageing Treatment Market, by Gender

  • 12.1. Female
  • 12.2. Male

13. Anti-Ageing Treatment Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Anti-Ageing Treatment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Anti-Ageing Treatment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Allergan Plc by AbbVie Inc.
  • 17.2. Alma Lasers Ltd.
  • 17.3. Amorepacific Corporation
  • 17.4. AVON Products, Inc.
  • 17.5. Bausch & Lomb Incorporated
  • 17.6. Beiersdorf AG
  • 17.7. Coty Inc.
  • 17.8. Cynosure, LLC
  • 17.9. DSM-Firmenich AG
  • 17.10. Evolus
  • 17.11. Galderma S.A.
  • 17.12. Kao Corporation
  • 17.13. Kenvue Inc.
  • 17.14. L'Oreal S.A.
  • 17.15. Mary Kay Inc.
  • 17.16. Merck KGaA
  • 17.17. Merz Aesthetics
  • 17.18. Natura & Co.
  • 17.19. Nu Skin International, Inc.
  • 17.20. Pierre Fabre S.A.
  • 17.21. Revance Aesthetics
  • 17.22. Shiseido Company, Limited
  • 17.23. Solta Medical, Inc.
  • 17.24. Syneron Medical Ltd.
  • 17.25. The Estee Lauder Companies Inc.
  • 17.26. The Procter & Gamble Company
  • 17.27. Unilever PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTI-AGEING TREATMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANTI-AGEING TREATMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANTI-AGEING TREATMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANTI-AGEING TREATMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTI-AGEING TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANTI-AGEING TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COSMETIC TREATMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COSMETIC TREATMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COSMETIC TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CHEMICAL PEELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CHEMICAL PEELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CHEMICAL PEELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CRYOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CRYOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CRYOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DERMAL FILLERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DERMAL FILLERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DERMAL FILLERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DOTOX INJECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DOTOX INJECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DOTOX INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LASER SKIN RESURFACING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LASER SKIN RESURFACING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LASER SKIN RESURFACING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICRODERMABRASION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MICRODERMABRASION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICRODERMABRASION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MICRONEEDLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MICRONEEDLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MICRONEEDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIOFREQUENCY SKIN TIGHTENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIOFREQUENCY SKIN TIGHTENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIOFREQUENCY SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TOPICAL TREATMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TOPICAL TREATMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TOPICAL TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTI-AGING CREAMS & SERUMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANTI-AGING CREAMS & SERUMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTI-AGING CREAMS & SERUMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANTIOXIDANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTIOXIDANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANTIOXIDANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PEPTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PEPTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RETINOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RETINOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RETINOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUNSCREENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SUNSCREENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUNSCREENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONE-TIME PRODUCT SALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONE-TIME PRODUCT SALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONE-TIME PRODUCT SALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REPEAT REPLENISHMENT MODEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REPEAT REPLENISHMENT MODEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REPEAT REPLENISHMENT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUBSCRIPTION SKINCARE MODEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SUBSCRIPTION SKINCARE MODEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUBSCRIPTION SKINCARE MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MONOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MONOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MONOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COMBINATION THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMBINATION THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COMBINATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AT-HOME TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AT-HOME TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AT-HOME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SALON/SPA TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SALON/SPA TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SALON/SPA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DERMATOLOGY CLINIC TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DERMATOLOGY CLINIC TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DERMATOLOGY CLINIC TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOSPITAL-BASED TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOSPITAL-BASED TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOSPITAL-BASED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DERMATOLOGISTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DERMATOLOGISTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DERMATOLOGISTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PLASTIC SURGEONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLASTIC SURGEONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PLASTIC SURGEONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL SPAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL SPAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL SPAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL WELLNESS PRACTITIONERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL WELLNESS PRACTITIONERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WELLNESS PRACTITIONERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FEMALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FEMALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FEMALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 166. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 168. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 170. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 190. G7 ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 193. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 194. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 195. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 197. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 199. NATO ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 202. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 203. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 204. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 206. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 218. CANADA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 221. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 223. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 225. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 227. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 232. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 234. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 236. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 239. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 241. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 243. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 257. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 258. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 259. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 261. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 268. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 270. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 272. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 275. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 276. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 277. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 279. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 286. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 288. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 290. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 293. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 294. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 295. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 297. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 308. INDIA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 309. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 311. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 312. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 313. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 315. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 317. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 320. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 321. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 322. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 324. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 326. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 330. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 335. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY COSMETIC TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 338. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 339. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 340. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 342. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)